|
| |
BioPortfolio's Approved Drugs DatabaseValsartanValsartanDownload PDF containing detailed information.
Press Releases About Valsartan:
|
 |
| Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results |
18th May, 2009 |
Lotus Pharmaceuticals, Inc. |
BEIJING, May 18 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc.
(OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a company that controls
and operates
|
| Leading Blood Pressure Medication Diovan(R) With Diuretic Reduces Key Sign of Artery Ageing Which is Linked to Risk of Heart Attack and Stroke |
5th June, 2008 |
|
BASEL, Switzerland, June 5 /PRNewswire/ --
- First Study to Show Diovan/HCT Improves Artery Elasticity in Patients
With Type 2 Diabetes, High Blood Pressure and Kidney Disease(1)
-
|
| Novartis launch largest diabetes prevention trial to date |
1st November, 2001 |
Novartis |
PRESS RELEASE
released on 10 Sept. 2001
Novartis launch
|
Companies working in the area of Valsartan from Bioportfolio's Biocorporate database : |  |
| Company Name | |
Synergix creates new lead prototype molecules with proven biological activities for pharmaceutical companies. Synergix has pioneered 'rational drug design' computerized technologies that positions the...
www.drugdesign.com/ View full profile
| |
This page has been viewed 62 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Valsartan across BioPortfolio, or for Valsartan Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|